Popular Articles

Health Trust Uses Complementary Treatments As Part Of Their "Improving Working Lives" Initiative
Workers in one of the largest PCT"s in the UK have been benefiting from a scheme that is part of the "improving working lives in the workplace" initiative. Since January 2009, training company, Ethos (Education, Training, Health and Online Service Ltd) have been working with staff across all disciplines within the trust including clinical and non-clinical staff on a programme of taster complementary therapy sessions.
generic viagra
Study Examines Efficacy Of Merck Drug On HIV Reservoirs
Patients who added Merck"s HIV drug Isentress to their regular daily HIV drug regimen "fared no better than those who added a placebo to the mix," as the drug failed to "reduce low-level reservoirs of HIV," in the body, according to findings presented at the International AIDS Society conference in Cape Town, South Africa, Bloomberg reports. As part of the 53-participant study led by Harvard University, researchers looked at patients whose viral loads were at undetectable levels and "were given either Isentress or a placebo for 12 weeks, then switched to the alternate agent for an additional 12 weeks. The study found no difference in low levels of the virus between the two groups, using a highly sensitive test," the article states. "The results are a setback for doctors looking for ways to seek and destroy the last vestiges of HIV, which aren"t reached by currently available drugs. Eliminating these so-called viral reservoirs may potentially cure patients, allowing them to stop taking daily medicines," according to Bloomberg (Pettypiece, 7/22).
News of the day
U.S. Health and Human Services Secretary Sebelius Releases New Report On Health Disparities
U.S. Health and Human Services (HHS) Secretary Kathleen Sebelius today released a new report on health disparities in America and participated in a White House Health Care Stakeholder Discussion on the importance of reform that reduces disparities that exist in our current health care system. The new report Health Disparities: A Case for Closing the Gap is available at http://www.HealthReform.gov.
Endocrinology

Physician Groups Support Comparative Effectiveness Provisions In Proposed Legislation

The American College of Physicians (ACP) have joined with two other physician groups to offer strong support for the Comparative Effectiveness Research (CER) provisions included in the Tri-Committee health reform bill about to be considered in the House. The Tri-Committee, which unveiled its proposed legislation on June 19, is made up of the House Ways and Means, Energy and Commerce, and Education and Labor Committees. This support was provided in a letter to the chairmen and ranking members of the three committees. The organizations - ACP, the American Academy of Family Physicians (AAFP) and the Society of General Internal Medicine (SGIM) - represent more than 200,000 physicians who treat patients every day, many of whom have multiple chronic conditions. "We know the value of having scientifically valid information available that permits physicians and their patients to make informed decisions on the most effective and appropriate treatment in individual cases. We also firmly believe that patient care will benefit if coverage decisions are informed by the best available science, including evidence on the clinical effectiveness of different treatments," said Jim King, MD, FAAFP, board chair of AAFP, Joseph W. Stubbs, MD, FACP, president of ACP and Nancy Rigotti, MD, FACP, president of SGIM "Comparative effectiveness research brings to the patient and physician the best chance of providing the right treatment to each patient in the most safe and effective manner. We know that better information on which treatments are most effective leads to better patient outcomes, less suffering, and more efficient use of limited healthcare res. Moreover, we agree with the approach of your bill, which makes clear the importance that this information must be the result of scientifically valid research, emanating from a trusted and dedicated solely to the development of comparative effectiveness research based on the best available science and through a transparent process," the letter continued. "We have great respect for the incredibly hard work your committees have undertaken in the enormous and complex objective of healthcare reform. As the bill moves through the House and eventually into a Conference Committee with the Senate, we urge you to hold fast to your positions on CER that will maintain it as a scientifically-based research initiative designed to benefit patients. CER should not be subjected to arbitrary legislative limits on use that could harm patients by denying them, their physicians, and their health plans with access to the best scientific evidence to improve the care patients receive." "Thank you for considering our views. We look forward to continuing to work with you in the weeks and months ahead as you endeavor to provide the American people with a healthcare system, with CER, that will work to their great benefit," the letter ended. David Kinsman American College of Physicians


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):